Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Genes & Genomics|December 1, 2018
Short rare minisatellite variant of BORIS-MS2 is related to bladder cancer susceptibilityTae Nam Kim, Won-Tae Kim, Mi-So Jeong, et al.Urology|July 4, 2012
Recovery of overall exercise ability, quality of life, and continence after 12-week combined exercise intervention in elderly patients who underwent radical prostatectomy: a randomized controlled studySung-Woo Park, Tae Nam Kim, Jong-Kil Nam, et al.Chemosphere|May 20, 2018
Non-selective rapid electro-oxidation of persistent, refractory VOCs in industrial wastewater using a highly catalytic and dimensionally stable IrPd/Ti composite electrodeWan-Cheol Cho, Kyung-Min Poo, Hend Omar Mohamed, et al.Genes & Genomics|June 8, 2024
Association between PDCD6-VNTR polymorphism and urinary cancer susceptibilityGi-Eun Yang, Min-Hye Kim, Mi-So Jeong, et al.BMC Medical Genomics|May 6, 2021
VNTR polymorphism in the breakpoint region of ABL1 and susceptibility to bladder cancerMin-Hye Kim, Gi-Eun Yang, Mi-So Jeong, et al.Cancers|June 4, 2020
Fanconi Anemia Pathway Activation by FOXM1 Is Critical to Bladder Cancer Recurrence and Anticancer Drug ResistanceYun-Gil Roh, Jeong-Yeon Mun, Seon-Kyu Kim, et al.Urology|June 29, 2014
Reasons for prescription change of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaTae Nam Kim, Jong Kil Nam, Ki Soo Lee, et al.The World Journal of Men'S Health|May 2, 2017
Clinicopathologic Characteristics and Treatment Outcomes of Penile CancerJong Kil Nam, Dong Hoon Lee, Sung Woo Park, et al.BMB Reports|February 6, 2018
Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1Yun-Gil Roh, Mi-Hye Mun, Mi-So Jeong, et al.Genes|January 23, 2024
Exploring the Relationship between CLPTM1L-MS2 Variants and Susceptibility to Bladder CancerMi-So Jeong, Jeong-Yeon Mun, Gi-Eun Yang, et al.Pageof 4